| ELI LILLY |
| USA |
| Gesundheit |
| US5324571083 / 858560 |
| LLY (Frankfurt) / LLY (NYSE) |
| FRA:LLY, ETR:LLY, LLY:GR, NYSE:LLY |
| S&P500 |
| https://www.lilly.com/ |
|
Eli Lilly and Company is a leading pharmaceutical company engaged in the discovery, development, manufacture, and sale of human pharmaceutical products. It focuses on innovative medicines addressing c..
>Volltext.. |
| 741268.23 Mio. EUR |
| 772449.49 Mio. EUR |
| 56160.47 Mio. EUR |
| 27306.66 Mio. EUR |
| 17782.67 Mio. EUR |
| 19.49 EUR |
| 37795.59 Mio. EUR |
| 6171.89 Mio. EUR |
| 14486.66 Mio. EUR |
| 0.21 |
| 27.54% |
| 71.77% |
| 5.32 EUR |
| 0.68% |
| 0.76% |
| 13.02.26 - 1.457352€ 14.11.25 - 1.2880499€ >weitere anzeigen... |
| - |
| ELI LILLY, LILLY DEUTSCHLAND |
| 25.03.26 |